Topline results from the VESTIGE Phase IV clinical trial evaluating the effect of Dupixent (dupilumab) on airway remodeling parameters through the use of functional respiratory imaging (FRI) in adults with uncontrolled moderate-to-severe asthma with an eosinophilic phenotype or with oral corticosteroid dependent asthma were presented in collaboration with Regeneron in a late-breaking poster session at the 2024 American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting.
For the symptomatic relief of acute chesty coughs and catarrh associated with influenza, colds and mild throat infections.
An expectorant for the relief of chesty coughs. For oral administration
Benylin Mucus Cough Max Honey & Lemon Flavour 100 mg/5 ml Syrup is indicated for the symptomatic relief of productive cough in adults and adolescents of 12 years and above.
Benylin Mucus Cough Max Menthol Flavour 100 mg/ 5 ml Oral Solution is indicated to help loosen phlegm and thin bronchial secretions associated with productive cough, for use in adults and adolescents over 12 years.
Kala Pharmaceuticals, Inc. a developer of innovative ophthalmic medicines based on its proprietary mucus-penetrating particle (MPP) technology, announced positive top-line...
Containing relevant Learning Zones, guidelines, trials and news.
Purpose: This phase III study compared SB3, a trastuzumab (TRZ) biosimilar, with reference TRZ in patients with human epidermal growth factor receptor 2–positive early breast cancer in the neoadjuvant setting (ClinicalTrials.gov identifier: NCT02149524).
Nasal decongestant and expectorant for the symptomatic relief of respiratory tract disorders.
BENYLIN Chesty Coughs (Non-drowsy) is indicated for the symptomatic relief of cough.